Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis
| Image |  |
|---|---|
| Description | scientific article published on 27 June 2020 |
| Author/s |
author: Steffen Koschmieder Nikolaus Marx |
| Publication date | June 27, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |